MPSC cancels Drug Inspector recruitment over paper leak
Analysis based on 49 articles · First reported Aug 25, 2026 · Last updated Sep 07, 2026
The cancellation of the Drug Inspector recruitment process has minimal direct market impact, as it affects a government hiring process rather than corporate earnings or financial markets. However, it may influence public sentiment regarding government transparency and could lead to increased scrutiny of examination processes, potentially affecting related service sectors.
The India — Maharashtra Public Service Commission (MPSC) cancelled the recruitment process for Drug Inspector, Group-B posts in the United States — Food and Drug Administration Department after a preliminary inquiry found prima facie evidence of malpractice in the screening examination held on March 22, 2026. Complaints received between July 22 and 26 alleged that some candidates had obtained the question paper before the exam, with material circulated via social media. The MPSC lodged a complaint with India — Greater Mumbai Police on July 27, and the India — Criminal Investigation Department's preliminary report indicated that one candidate had received the question set and benefited. The commission cancelled the entire recruitment process to maintain integrity and transparency, and announced a fresh examination for which candidates need not reapply or pay fees. The cancellation comes amid heightened scrutiny of public examinations in India, including protests over NEET-UG and JPSC-JSSC paper leaks. Political figures, including India — Maharashtra Navnirman Sena leader Sandeep Deshpande and India — Nationalist Congress Party – Sharadchandra Pawar MLA Ajit Pawar, have questioned the handling of the leak, with Pawar alleging the paper was sold for Rs 40 lakh each. A BJP leader stated that Chief Minister Devendra Fadnavis promised a thorough investigation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard